Muscle biopsy findings in inflammatory myopathies (Q35036178)

5 August 2017

1 reference

title

Muscle biopsy findings in inflammatory myopathies (English)

1 reference

5 August 2017

0 references

Marinos C Dalakas

1

1 reference

5 August 2017

publication date

1 November 2002

1 reference

Rheumatic Diseases Clinics of North America

5 August 2017

published in

1 reference

5 August 2017

volume

28

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

779-98, vi

1 reference

Polymyositis, dermatomyositis and inclusion-body myositis

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Immunopathogenesis of inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

The immunobiology of muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Microvascular deposition of complement membrane attack complex in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Inclusion body myositis: new concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: diseases of oxidative stress and aging?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Rimmed vacuoles with beta-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): similarities with inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Expression of immunoreactive major histocompatibility complex products in human skeletal muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Cytokine expression profile in idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Microvascular changes in early and advanced dermatomyositis: a quantitative study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Dermatomyostis of childhood, ultrastructural alteratious of muscle and intramuscular blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Neuromuscular diseases associated with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Inclusion body myositis and myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian Jews

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Common variable immunodeficiency and inclusion body myositis: a distinct myopathy mediated by natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Immunocytochemical localization of ubiquitin in inclusion body myositis allows its light‐microscopic distinction from polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

The molecular and cellular pathology of inflammatory muscle diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Polymyositis associated with AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Polymyositis in patients infected with human T-cell leukemia virus type I: the role of the virus in the cause of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Immunocytochemical and virological characteristics of hiv-associated inflammatory myopathies: Similarities with seronegative polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

Inclusion body myositis in HIV-1 and HTLV-1 infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900030-3

7 January 2021

10.1016/S0889-857X(02)00030-3

Identifiers

DOI

1 reference

5 August 2017

1 reference